D’ApolitoOPianesPSalviaG. Plasma levels of conjugated bile acids in newborn after a short period of total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010;34:538-541.
2.
KellyDA. Intestinal failure-associated liver disease: what do we know today?Gastroenterology. 2006;130(2 suppl 1):S70-S77.
3.
CavicchiMBeauPCrennPDegottCMessingB. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525-532.
4.
ColombVJobert-GiraudALacailleFGouletOFournetJCRicourC. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000;24:345-350.
5.
GuraKMLeeSValimC. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121:e678-e686.
6.
DasJBMossRLRaffenspergerJG. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg. 1993;28:1270-1274.
7.
DemircanMErgunOAvanogluSYilmazFOzokG. Determination of serum bile acids routinely may prevent delay in diagnosis of total parenteral nutrition-induced cholestasis. J Pediatr Surg. 1999;34:565-567.
8.
TribeRMDannATKenyonAPSeedPShennanAHMalletA. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy. Am J Gastroenterol. 2010;105:585-595.
